Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |